The patient monitoring market includes diagnostic and measurement devices, exhalation monitors, multiparameter patient monitoring, neonatal monitors, operating room Integration systems, and remote patient monitoring. Exhalation monitors uses values such as breathing frequency, minute ventilation, breathing effort are measured in case of mild respiratory disorders. GlobalData uses proprietary data and analytics to provide a comprehensive report on the exhalation monitors devices market, including market shares of different players within the US. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the exhalation monitors market in the US was Koninklijke Philips followed by Vyaire Medical, Medtronic, Pulmonx and Dragerwerk AG &CoKGaA.
Accurate monitoring and analyzing of these values tend to early recognition and treatment of Chronic respiratory failure.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the exhalation monitors devices market within the US was expected to be over $8800m in 2022.
For the latest complete market share analysis of exhalation monitors device market in the US, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
